Profile data is unavailable for this security.
About the company
Alliance Pharma plc is a United Kingdom-based international consumer healthcare company. The principal activity of the Company is to act as a holding company. The principal activity of the Company is the acquisition, marketing and distribution of consumer healthcare and pharmaceutical products. Its segments include Consumer Healthcare brands and Prescription Medicines. Its Consumer Healthcare brands include the Kelo-Cote franchise, Amberen, Nizoral, MacuShield, Aloclair, Vamousse, and other consumer healthcare brands. Its Prescription Medicines include Hydromol, Flamma Franchise, Forceval and other prescription medicines. Its products include Aloclair Plus Gel, Aloclair Plus Spray, Aloclair Plus Mouthwash, Anbesol Adult Strength Gel, Anbesol Teething Gel, Anbesol Liquid, Atopiclair Cream, and Atopiclair Lotion. It holds marketing rights to around 80 consumer healthcare brands and prescription medicines, which are sold worldwide in more than 100 countries.
- Revenue in GBP (TTM)183.15m
- Net income in GBP-33.58m
- Incorporated2001
- Employees290.00
- LocationAlliance Pharma PLCAvonbridge House, Bath RoadCHIPPENHAM SN15 2BBUnited KingdomGBR
- Phone+44 12 4946 6966Fax+44 12 4946 6977
- Websitehttps://www.alliancepharmaceuticals.com/
Peer analysis
Company | Revenue (TTM) | Net income (TTM) |
---|---|---|
Cipher Pharmaceuticals Inc | 16.89m | 17.22m |
Themis Medicare Ltd | 37.02m | 4.54m |
VIVA Biotech Holdings | 216.63m | -34.53k |
Aurora Cannabis Inc | 156.48m | -16.71m |
Alliance Pharma plc | 183.15m | -33.58m |
Natac Natural Ingredients SA | 38.23m | 7.36m |
PharmaSGP Holding SE | 91.83m | 15.24m |
Golden Throat Holdings Group Co Ltd | 109.25m | 28.47m |
Institutional shareholders
Holder | Shares | % Held |
---|---|---|
Slater Investments Ltd.as of 22 Jul 2024 | 70.68m | 13.08% |
Rathbones Investment Management Ltd.as of 06 Oct 2023 | 25.97m | 4.81% |
Fidelity Management & Research Co. LLCas of 11 Jun 2024 | 19.64m | 3.64% |
Artemis Investment Management LLPas of 11 Jun 2024 | 17.35m | 3.21% |
Van Lanschot Kempen Investment Management NVas of 18 Jun 2024 | 15.02m | 2.78% |
RBC Global Asset Management (UK) Ltd.as of 25 Aug 2023 | 14.55m | 2.69% |
Rowan Dartington & Co. Ltd. (Broker)as of 01 Jun 2024 | 14.44m | 2.67% |
Brooks Macdonald Asset Management Ltd.as of 01 Jun 2024 | 11.93m | 2.21% |
Polar Capital LLPas of 01 Jun 2024 | 11.21m | 2.08% |
Bill & Melinda Gates Foundation Trust (Investment Management)as of 01 Jun 2024 | 10.50m | 1.94% |